These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6690630)

  • 21. [Testing the loss of efficacy (tachyphylaxis) during external steroid application].
    Koch EM; Jurgovsky E
    Hautarzt; 1985 Mar; 36(3):146-9. PubMed ID: 3997512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of penetration-enhancing ability of laurocapram, N-methyl-2-pyrrolidone and dodecyl-L-pyroglutamate.
    Príborský J; Takayama K; Nagai T; Waitzová D; Elis J; Makino Y; Suzuki Y
    Pharm Weekbl Sci; 1988 Oct; 10(5):189-92. PubMed ID: 3060835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of vehicles and enhancers on the topical delivery of cyclosporin A.
    Liu H; Li S; Wang Y; Yao H; Zhang Y
    Int J Pharm; 2006 Mar; 311(1-2):182-6. PubMed ID: 16439077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioavailability and activity of betamethasone 17-benzoate in gel and cream formulations: comparison with proprietary topical corticosteroid preparations in the vasoconstrictor assay.
    Woodford R; Barry BW
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):338-45. PubMed ID: 4208350
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human skin.
    Barry BW; Bennett SL
    J Pharm Pharmacol; 1987 Jul; 39(7):535-46. PubMed ID: 2886623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation of application time to bioactivity of a potent topical glucocorticoid formulation.
    Stoughton RB; Wullich K
    J Am Acad Dermatol; 1990 Jun; 22(6 Pt 1):1038-41. PubMed ID: 2370328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diflorasone diacetate: vasoconstrictor activity and clinical efficacy of a new topical corticosteroid.
    Bluefarb SM; Howard FM; Leibsohn E; Schlagel CA; Wexler L
    J Int Med Res; 1976; 4(6):454-61. PubMed ID: 800385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of the Compatibility of the Skin PAMPA Model with Topical Formulation and Acceptor Media Additives Using Different Assay Setups.
    Köllmer M; Mossahebi P; Sacharow E; Gorissen S; Gräfe N; Evers DH; Herbig ME
    AAPS PharmSciTech; 2019 Jan; 20(2):89. PubMed ID: 30680544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous permeation of N,N-diethyl-m-toluamide (DEET) from commercial mosquito repellents and the effect of solvent.
    Stinecipher J; Shah J
    J Toxicol Environ Health; 1997 Oct; 52(2):119-35. PubMed ID: 9310145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-frequency ultrasound sonophoresis to increase the efficiency of topical steroids: a pilot randomized study of humans.
    Maruani A; Boucaud A; Perrodeau E; Gendre D; Giraudeau B; Machet L
    Int J Pharm; 2010 Aug; 395(1-2):84-90. PubMed ID: 20472045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous absorption of betamethasone 17-benzoate measured by radioimmunoassay.
    Mizuchi A; Miyachi Y; Tamaki K; Kukita A
    J Invest Dermatol; 1976 Aug; 67(2):279-82. PubMed ID: 781144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human volunteer study on the influence of exposure duration and dilution of dermally applied N-methyl-2-pyrrolidone (NMP) on the urinary elimination of NMP metabolites.
    Keener SA; Wrbitzky R; Bader M
    Int Arch Occup Environ Health; 2007 Feb; 80(4):327-34. PubMed ID: 16897094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human experimental exposure to N-methyl-2-pyrrolidone (NMP): toxicokinetics of NMP, 5-hydroxy- N-methyl-2-pyrrolidone, N-methylsuccinimide and 2-hydroxy- N-methylsuccinimide (2-HMSI), and biological monitoring using 2-HMSI as a biomarker.
    Jönsson BA; Akesson B
    Int Arch Occup Environ Health; 2003 May; 76(4):267-74. PubMed ID: 12684812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psoriasis treatment with betamethasone dipropionate using short-term application and short-term occlusion.
    Jaeger L
    Acta Derm Venereol; 1986; 66(1):84-7. PubMed ID: 2424228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organic solvents as vehicles for precipitating liquid embolics: a comparative angiotoxicity study with superselective injections of swine rete mirabile.
    Dudeck O; Jordan O; Hoffmann KT; Okuducu AF; Tesmer K; Kreuzer-Nagy T; Rüfenacht DA; Doelker E; Felix R
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):1900-6. PubMed ID: 17032862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dermal exposure to aqueous solutions of N-methyl pyrrolidone.
    Akrill P; Cocker J; Dixon S
    Toxicol Lett; 2002 Aug; 134(1-3):265-9. PubMed ID: 12191887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind controlled comparison of generic and trade-name topical steroids using the vasoconstriction assay.
    Olsen EA
    Arch Dermatol; 1991 Feb; 127(2):197-201. PubMed ID: 1990984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. STABILITY OF SOLUTIONS OF 2,3-DIPHENYLCYCLOPROPENONE IN VARIOUS SOLVENTS. A NOVEL FORMULA - DIPHENYLCYCLOPROPENONE IN ISOPROPANOL MAY BE USEFUL IN TOPICAL THERAPY OF PATIENTS WITH ALOPECIA AREATA.
    Borowska K; Wasylyszyn T
    Acta Pol Pharm; 2017 Mar; 74(2):459-464. PubMed ID: 29624251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of inert ingredients in pesticide formulations on dermal absorption of carbaryl.
    Baynes RE; Riviere JE
    Am J Vet Res; 1998 Feb; 59(2):168-75. PubMed ID: 9492931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.